InsidersTradesSigma
Explore the full record of transactions filed by Wigzell Hans Lennart Rudolf, Directeur. Insider active across 1 companies, notably Sarepta Therapeutics, Inc.. Cumulatively, 1 filings have been logged. The latest transaction was filed on 7 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Wigzell Hans Lennart Rudolf is a Director at Sarepta Therapeutics, Inc. He plays a key role in the governance of the company, participating in strategy development and performance oversight. His expertise helps guide management and ensure compliance with regulations.